A data-driven analysis of evolving payment trends in clinical allergy care.
This publication presents findings from more than 10 million claims spanning Medicare, Medicaid, and commercial payors. The objective: to understand how reimbursement, cost structures, and emerging therapies are reshaping the economics of allergy practice.
This report is intended for clinicians and administrators who want to examine reimbursement not as a billing function, but as a clinical operations variable that influences care delivery, workforce allocation, and long-term practice sustainability.
Inside the report, you will explore:
A quantitative comparison showing how routine allergy services are being devalued relative to rising extract, staffing, and equipment costs.
Why biologics and infusion services are altering the financial profile of allergy practices—and what that signals for resource allocation.
How reimbursement variability for the same CPT codes creates unpredictable margins and challenges assumptions about contracting.
An evidence review of the growing out-of-pocket burden and its implications on access, utilization, and collections.
Insight into why a small subset of practices now consistently outperform peers: a structural, not incidental, trend.
Reimbursement patterns are not simply financial outcomes—they shape:
Understanding these shifts is essential for any practice evaluating its clinical and operational strategy over the next decade.
Access the full analysis and review comparative metrics, data visualizations, and methodology that support this emerging view of Allergy & Immunology reimbursement.
